2-Morpholino-5-(trifluoromethyl)benzoic acid, 97.0%, 5g

METHYL 2-(1,5-NAPHTHYRIDIN-2-YL)ACETATE, 95.0%, 500mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-bromophenyl)propanoic acid, 98%, 250mg

5-(Dimethylamino)pyridazin-3(2H)-one hydrochloride, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-((tert-butoxycarbonyl)amino)phenyl)propanoic acid, 98%, 5g

(2E)-1-(2,4-dimethoxyphenyl)-3-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

(R)-4-(Hydroxymethyl)-1-((R)-1-phenylethyl)pyrrolidin-2-one, 95.0%, 100mg

Methyl 3-bromo-2,2-difluoropropanoate, 97.0%, 1g

Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate, 95.0%, 10g

6-Bromo-2-methyl-1,3-benzothiazole, 95.0%, 1g

Ethyl 2-Hydroxycyclopentanecarboxylate, 97.0%, 100g

4-Fluoro-5-iodo-1H-pyrrolo[2,3-b]pyridine, 98%, 100mg

Orotic acid monohydrate, min. 99%, 10 g, plastic packaging.